Director/PDMR Shareholding

RNS Number : 8000T

Epistem Holdings plc

04 October 2010

 



Epistem Holdings Plc ("Epistem" or the "Company")

Directors' Shareholdings

Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.

As a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors have each increased their beneficial interest in the Company by 144 ordinary shares of 1.5p each. These shares were acquired in tranches on 12^th and 16^th July 2010 at prices of 364p and 362p respectively.

The current beneficial interests of the executive Directors are set out below:

Matthew Walls                             7,327                                   (0.09%)

Dr Catherine Booth                  981,682                                  (12.37%)

Dr Ged Brady                              1,682                                   (0.02%)

Dr Jeffrey Moore                        16,182                                   (0.20%)          

John Rylands                            191,580                                   (2.41%)

For further details please contact:

Epistem Plc

Matthew Walls, CEO                                                               [phone]

John Rylands, CFO                                                                  [phone]

KBC Peel Hunt Ltd.

James Steel / Vijay Barathan                                                     [phone]

 

END

 

 

RDSBBBDGLGGBGGS